# Coya Therapeutics, Inc.: Form 8-K, filed Aug 19, 2024

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 8-K
- Filed: 2024-08-19
- Accepted by EDGAR: Aug 19, 2024, 09:10 ET
- Period: 2024-08-16
- Accession: 0001193125-24-202551
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000119312524202551/d861081d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000119312524202551/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000119312524202551/d861081d8k.htm

Filed Aug 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-202551. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
